Regulation of vascular tone from spontaneously hypertensive rats by the HMG-CoA reductase inhibitor, simvastatin

被引：14

作者：

Pérez-Guerrero, C ^{[1
]}

Márquez-Martín, A ^{[1
]}

Herrera, MD ^{[1
]}

Marhuenda, E ^{[1
]}

de Sotomayor, MA ^{[1
]}

机构：

[1] Univ Seville, Fac Pharm, Dept Pharmacol, ES-41012 Seville, Spain

来源：

PHARMACOLOGY | 2005年 / 74卷 / 04期

关键词：

HMG-CoA reductase; simvastatin; calcium; Rho-kinase; spontaneously hypertensive rat;

D O I：

10.1159/000085957

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The acute effect of simvastatin on aortic rings from spontaneously hypertensive rats (SHRs) was identified. Simvastatin-evoked relaxations of both depolarized and phenylephrine-precontracted arteries were independent of the presence of endothelium. This effect was inhibited by diltiazem and mevalonate, but not by the Rho-kinase inhibitor, Y-27632. Simvastatin prevented contraction induced by phenylephrine, calcium ionophore A-23187 and CaCl2 in Ca2+- free medium. Y-27632 decreased the effect of simvastatin. On the contrary, contraction induced by noradrenaline in Ca2+- free medium was not affected. These results suggest that simvastatin elicited an effect on vascular smooth muscle cells from SHRs that may involve blockade of extracellular calcium entry and decrease vascular contraction by affecting Rho-kinase. Copyright (C) 2005 S. Karger AG, Basel.

引用

页码：209 / 215

页数：7

共 50 条

[41] Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait
Danish Iqbal
M Salman Khan
Mohd Sajid Khan
Saheem Ahmad
Md Sarfaraj Hussain
Mohd Ali
Lipids in Health and Disease, 14
[42] HMG-CoA reductase inhibitorsFirst report of decreased libido with atorvastatin, fluvastatin, pravastatin and simvastatin: 8 case reports
Reactions Weekly, 2005, 1039 (1) : 9 - 9
[43] Design of Tetrapeptides as a Competitive Inhibitor for HMG-CoA Reductase and Modeling Recognized Sequence as a β-Turn Structure
Pak, Valeriy V.
Khojimatov, Olim K.
Pak, Aleksandr, V
Sagdullaev, Shomansur Sh
Yun, Lyubov
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2022, 28 (05)
[44] Kinetic characterization of an oxidative, cooperative HMG-CoA reductase from Burkholderia cenocepacia
Schwarz, Benjamin H.
Driver, Joseph
Peacock, Riley B.
Dembinski, Holly E.
Corson, Melissa H.
Gordon, Samuel S.
Watson, Jeffrey M.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2014, 1844 (02): : 457 - 464
[45] Design of Tetrapeptides as a Competitive Inhibitor for HMG-CoA Reductase and Modeling Recognized Sequence as a β-Turn Structure
Valeriy V. Pak
Olim K. Khojimatov
Aleksandr V. Pak
Shomansur Sh. Sagdullaev
Lyubov Yun
International Journal of Peptide Research and Therapeutics, 28
[46] Molecular docking, synthesis and biological evaluation of ergosteryl-ferulate as a HMG-CoA reductase inhibitor
Aziz, Syaikhul
Elfahmi
Soemardji, Andreanus A.
Sukrasno
PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 33 (03) : 997 - 1003
[47] The protective effect of simvastatin against low dose streptozotocin induced type 1 diabetes in mice is independent of inhibition of HMG-CoA reductase
Rydgren, Tobias
Sandler, Stellan
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 379 (04) : 1076 - 1079
[48] Modified HMG-CoA reductase and LDLr regulation is deeply involved in age-related hypercholesterolemia
Pallottini, Valentina
Martini, Chiara
Cavallin, Gabriella
Donati, Alessio
JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 98 (05) : 1044 - 1053
[49] Rhabdomyolysis and acute renal failure associated with the co-administration of daptomycin and an HMG-CoA reductase inhibitor
Odero, Randy O.
Cleveland, Kerry O.
Gelfand, Michael S.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1299 - 1300
[50] Molecular rationale delineating the role of lycopene as a potent HMG-CoA reductase inhibitor: in vitro and in silico study
Alvi, Sahir Sultan
Iqbal, Danish
Ahmad, Saheem
Khan, M. Salman
NATURAL PRODUCT RESEARCH, 2016, 30 (18) : 2111 - 2114

← 1 2 3 4 5 →